- Home
- GSUN vs XRTX Comparison
GSUN vs XRTX Comparison
Compare GSUN & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSUN
- XRTX
- Stock Information
- Founded
- GSUN 1997
- XRTX 2011
- Country
- GSUN China
- XRTX Canada
- Employees
- GSUN N/A
- XRTX N/A
- Industry
- GSUN Other Consumer Services
- XRTX Pharmaceuticals and Biotechnology
- Sector
- GSUN Real Estate
- XRTX Health Care
- Exchange
- GSUN Nasdaq
- XRTX Nasdaq
- Market Cap
- GSUN 5.2M
- XRTX 5.0M
- IPO Year
- GSUN 2022
- XRTX N/A
- Fundamental
- Price
- GSUN $2.81
- XRTX $1.33
- Analyst Decision
- GSUN
- XRTX Strong Buy
- Analyst Count
- GSUN 0
- XRTX 1
- Target Price
- GSUN N/A
- XRTX $14.00
- AVG Volume (30 Days)
- GSUN 41.1K
- XRTX 22.7K
- Earning Date
- GSUN 11-26-2024
- XRTX 11-29-2024
- Dividend Yield
- GSUN N/A
- XRTX N/A
- EPS Growth
- GSUN N/A
- XRTX N/A
- EPS
- GSUN N/A
- XRTX N/A
- Revenue
- GSUN $6,336,931.00
- XRTX N/A
- Revenue This Year
- GSUN N/A
- XRTX N/A
- Revenue Next Year
- GSUN N/A
- XRTX N/A
- P/E Ratio
- GSUN N/A
- XRTX N/A
- Revenue Growth
- GSUN N/A
- XRTX N/A
- 52 Week Low
- GSUN $2.21
- XRTX $1.09
- 52 Week High
- GSUN $11.20
- XRTX $7.00
- Technical
- Relative Strength Index (RSI)
- GSUN 40.37
- XRTX 41.92
- Support Level
- GSUN $2.42
- XRTX $1.29
- Resistance Level
- GSUN $3.27
- XRTX $1.42
- Average True Range (ATR)
- GSUN 0.34
- XRTX 0.15
- MACD
- GSUN 0.12
- XRTX -0.01
- Stochastic Oscillator
- GSUN 32.00
- XRTX 18.75
About GSUN Golden Sun Education Group Limited
Golden Sun Health Technology Group Ltd is engaged in the provision of education and management services in the People's Republic of China. It offers tutorial centers for children and adults, one educational company that partners with high schools to offer language classes to their students, and one logistics company that provides logistic and consulting services. The company operates in two segments; Education segment and the Wellness segment. Majority of the revenue is generated from the Education segment which offers foreign language tutorial services and other education training management services in China. The wellness segment offers wellness service and related products.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.